Will Ranbaxy Tie Up With Teva To Launch Generic Lipitor?
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - Breaking a long silence, Ranbaxy Laboratories Ltd. Managing Director Arun Sawhney told investors last week that he is "very optimistic" about keeping the U.S. launch date of generic versions of Lipitor (atorvastatin), the largest pharmaceutical brand